Lexaria Bioscience (LEXX) Shares Outstanding (Diluted) (2010 - 2026)
Lexaria Bioscience (LEXX) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 64.41 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 115.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 138.28 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 556.90 Mn |
| 10 | Lexaria Bioscience | 10.15 Mn | 6.54 Mn | - | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 24.81 Mn |
| Feb 28, 2026 | 24.44 Mn |
| Nov 30, 2025 | 21.38 Mn |
| Aug 31, 2025 | 18.00 Mn |
| May 31, 2025 | 18.30 Mn |
| Feb 28, 2025 | 17.51 Mn |
| Nov 30, 2024 | 16.67 Mn |
| Aug 31, 2024 | 12.38 Mn |
| May 31, 2024 | 13.86 Mn |
| Feb 29, 2024 | 10.77 Mn |
| Nov 30, 2023 | 9.05 Mn |
| Aug 31, 2023 | 6.61 Mn |
| May 31, 2023 | 602,640.00 |
| Feb 28, 2023 | 602,640.00 |
| Nov 30, 2022 | 602,640.00 |
| Aug 31, 2022 | 602,640.00 |
| May 31, 2022 | 602,640.00 |
| Feb 28, 2022 | 602,640.00 |
| Nov 30, 2021 | 602,640.00 |
| Aug 31, 2021 | 602,640.00 |